Bronfman Ends Paramount Bid as Eli Lilly Reduces Weight-Loss Drug Prices

Reported about 2 months ago

Edgar Bronfman Jr. has withdrawn his bid for Paramount Global, paving the way for Skydance Media's acquisition of the studio. Simultaneously, Eli Lilly has significantly lowered the price of its weight-loss drug, Zepbound, with the lowest dose now priced at $399, down from $1,059, while the 5 mg dose will be available for $549 per month.

Source: YAHOO

View details

You may also interested in these wikis

Back to all Wikis